Licensing and Alliances

NMS is strategically committed to setting up partnerships in an endeavour to promote discovery and development of innovative cancer treatments.

NMS proposes to establish R&D collaborative undertakings with the aim of discovering and developing novel targeted cancer treatments. Innovative technologies, drug development and manufacturing processes are emphasised.

Company aims to set up focused alliances with biotechs and drug companies in the field of oncology, thus expanding the company's already established pipeline.

NMS will act as partner in advanced clinical drug trials in order to enhance development and commercialisation of new products on regional or global markets.